A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β2-agonists for asthma maintenance treatment in Germany
暂无分享,去创建一个
[1] M. Roth. Budesonide/Formoterol , 2012, Drugs.
[2] Wilcox,et al. HAS ASTHMA CONTROL IMPROVED SINCE AIRE? RESULTS OF A SURVEY IN 5 EUROPEAN COUNTRIES , 2010 .
[3] G. Guyatt,et al. The safety of formoterol among patients with asthma using inhaled corticosteroids. Systematic review and meta-analysis. , 2008, Polskie Archiwum Medycyny Wewnetrznej.
[4] H. Magnussen,et al. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. , 2007, Respiratory medicine.
[5] M. Reed,et al. Scottish Intercollegiate Guidelines Network (SIGN) 84 -- National Clinical Guideline for the Management of Breast Cancer in Women. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).
[6] D. Ryan,et al. Systematic review and meta-analysis of budesonide/formoterol in a single inhaler , 2007, Current medical research and opinion.
[7] P. Kuna,et al. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations , 2007, International journal of clinical practice.
[8] P. Gibson,et al. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations. , 2007, The Journal of allergy and clinical immunology.
[9] B. Bender,et al. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. , 2006, The Journal of allergy and clinical immunology.
[10] C. Lemière,et al. Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. , 2006, The Journal of allergy and clinical immunology.
[11] A. Chuchalin,et al. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. , 2006, Respiratory medicine.
[12] D. Price,et al. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? , 2005, European Respiratory Journal.
[13] J. C. Carranza Rosenzweig,et al. Adherence to asthma controller medication regimens. , 2005, Respiratory medicine.
[14] R. Angus,et al. Short‐acting β2‐agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long‐acting β2‐agonist or salmeterol/fluticasone propionate combination , 2005, International journal of clinical practice.
[15] P. O'Byrne,et al. An economic evaluation of combination treatment with budesonide and formoterol in patients with mild-to-moderate persistent asthma. , 2004, Respiratory medicine.
[16] R. Pauwels,et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. , 2004, American journal of respiratory and critical care medicine.
[17] J. C. Carranza Rosenzweig,et al. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. , 2004, The Journal of allergy and clinical immunology.
[18] V. Backer,et al. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma , 2004, Current medical research and opinion.
[19] S. Borg,et al. Budesonide/formoterol in a single inhaler (Symbicort) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 months. , 2003, International journal of clinical practice.
[20] N. Thomson,et al. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. , 2003, Chest.
[21] E. Bateman,et al. Combination Therapy with Single Inhaler Budesonide/Formoterol Compared with High Dose of Fluticasone Propionate Alone in Patients with Moderate Persistent Asthma , 2003, American journal of respiratory medicine : drugs, devices, and other interventions.
[22] British guideline on the management of asthma. , 2003, Thorax.
[23] A Tattersfield,et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. , 2001, American journal of respiratory and critical care medicine.
[24] O. Zetterström,et al. Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. , 2001, The European respiratory journal.
[25] W. Lumry,et al. Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma , 2000 .
[26] W. Lumry,et al. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma. , 2000, American journal of respiratory and critical care medicine.
[27] D. Postma,et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. , 1997, The New England journal of medicine.